Delivery Order SPE2DB22D2206-SPE2DB24FGE28
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, with a ceiling value of $1,451.99, is for the delivery of 4564118076 - Entecavir 0.5 MG Tablets (30s) to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $7,259.18, is for the delivery of the pharmaceutical product Entecavir 0.5 mg Tablets. The ultimate completion date for this delivery order is April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also been...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The award is for the supply of Entecavir 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $1,575.35 and a completion date of August 1, 2024. This order is issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to procure a comprehensive range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract has a ceiling value of $1,918.82 and provides for the delivery of Entecavir 0.5 mg tablets, a pharmaceutical product, to support military treatment programs and medical facilities. The contract is part of a larger indefinite delivery contract (IDC)...
- This contract award to Amerisourcebergen Drug Corp is for the delivery of 4,563,253,412 tablets of the pharmaceutical Entecavir 0.5 mg. The $3,653.83 firm fixed price Delivery Order was issued by the Defense Logistics Agency (DLA) on January 6, 2024, with an ultimate completion date of January 8, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,337.46. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count configuration. This is a firm fixed price delivery order with a ceiling value of $2,640.56 and an ultimate completion date of September 24, 2025. The award is not set-aside and represents a competitive award to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania. The contract will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Entecavir 0.5 mg tablets (30-count packages) with a ceiling value of $1,442.99. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award has a ceiling value of $3,954.80 and a completion date of August 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGE28Delivery Order
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,564,016,349 units of the pharmaceutical product Entecavir 0.5 mg Tablet 30s. The order has a ceiling value of $3,025.98 and an ultimate completion date of March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract. Amerisourcebergen Corporation is the parent company of the prime contractor, Amerisourcebergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/19/24 |